As on May 19, 2021, Altimmune Inc. (NASDAQ: ALT) got off with the flyer as it spiked 0.14% to $14.09. During the day, the stock rose to $14.4324 and sunk to $13.59 before settling in for the price of $14.07 at the close. Taking a more long-term approach, ALT posted a 52-week range of $4.58-$35.10.
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was -5.10%. Meanwhile, its Annual Earning per share during the time was 34.70%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -19.70%. This publicly-traded company’s shares outstanding now amounts to $36.37 million, simultaneously with a float of $30.93 million. The organization now has a market capitalization sitting at $498.36 million. At the time of writing, stock’s 50-day Moving Average stood at $13.92, while the 200-day Moving Average is $14.69.
Let’s gauge the efficiency of the firm, which has a total of 43 employees. It has generated 190,349 per worker during the last fiscal year. Meanwhile, its income per employee was -1,140,569. The stock had 1.17 Receivables turnover and 0.05 Total Asset turnover. For the Profitability, stocks operating margin was -470.78 and Pretax Margin of -665.38.
Altimmune Inc. (ALT) Ownership Facts and Figures
Another important factor to analyze is how key investors are playing towards the stock of the Biotechnology industry. Altimmune Inc.’s current insider ownership accounts for 1.00%, in contrast to 58.30% institutional ownership. According to the most recent insider trade that took place on Mar 01, this organization’s Director sold 6,000 shares at the rate of 16.08, making the entire transaction reach 96,480 in total value, affecting insider ownership by 8,731. Preceding that transaction, on Dec 10, Company’s Director bought 2,000 for 11.99, making the whole transaction’s value amount to 23,980. This particular insider is now the holder of 8,900 in total.
Altimmune Inc. (ALT) Earnings and Revenue Records
If we go through the results of last quarter, which was made public on 3/30/2021, the company posted -$0.38 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -$0.47) by $0.09. This company achieved a net margin of -599.20 while generating a return on equity of -36.14. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.58 per share during the current fiscal year.
Altimmune Inc.’s EPS decrease for this current 12-month fiscal period is -19.70% and is forecasted to reach 0.70 in the upcoming year.
Altimmune Inc. (NASDAQ: ALT) Trading Performance Indicators
Let’s observe the current performance indicators for Altimmune Inc. (ALT). It’s Quick Ratio in the last reported quarter now stands at 19.20. The Stock has managed to achieve an average true range (ATR) of 0.92. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 60.78.
In the same vein, ALT’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -2.02, a figure that is expected to reach -0.47 in the next quarter, and analysts are predicting that it will be 0.70 at the market close of one year from today.
Technical Analysis of Altimmune Inc. (ALT)
Through scrutinizing the latest numbers posted by the [Altimmune Inc., ALT], it can be observed that its last 5-days Average volume of 0.95 million was lower the volume of 1.41 million, it posted the year before. During the previous 9 days, stock’s Stochastic %D was recorded 82.51% While, its Average True Range was 0.95.
Raw Stochastic average of Altimmune Inc. (ALT) in the period of the previous 100 days is set at 25.65%, which indicates a major fall in contrast to 68.73% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 47.06% that was lower than 95.53% volatility it exhibited in the past 100-days period.